Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.29%

GeoVax Labs, Inc. (GOVX)

-Other OTC
0.25 Up 0.01(2.08%) 12:47PM EDT
ProfileGet Profile for:
GeoVax Labs, Inc.
1900 Lake Park Drive
Suite 380
Smyrna, GA 30080
United States - Map
Phone: 678-384-7220
Fax: 678-384-7283

Index Membership:N/A
Full Time Employees:6

Business Summary 

GeoVax Labs, Inc. operates as a biotechnology company. The company’s develops vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). Its vaccines incorporate two delivery components, including a recombinant DNA and recombinant poxvirus, known as modified vaccinia Ankara, which deliver genes that encode inactivated HIV derived proteins to the immune system. The company’s vaccines under development addressing the clade B subtype of the HIV virus includes GOVX-B11 and GOVX-B21 vaccines that are n Phase I clinical trials to prevent HIV infection, and to serve as a therapy for individuals who are already infected with HIV. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on GeoVax Labs, Inc.

Key Executives 
Dr. Robert T. McNally Ph.D., 66
Chief Exec. Officer, Pres and Director
Dr. Harriet Latham Robinson Ph.D., 76
Co-Founder, Chief Scientific Officer and Director
Mr. Mark W. Reynolds CPA, 52
Chief Financial Officer, Principal Accounting Officer and Corp. Sec.
Mr. Donald G. Hildebrand , 73
Founder, Chairman Emeritus and Consultant
Dr. Arban Domi Ph.D.,
Director of Vector Devel.
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders